Macrogenics (MGNX) Misses Q3 EPS by 19c

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of ($1.28), $0.19 worse than the analyst estimate of ($1.09). Revenue for the quarter came in at $1.66 million versus the consensus estimate of $4.11 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
• Corpay agrees to $100M FTC settlement over marketing practices